RISS 학술연구정보서비스

검색

인기 검색어

    다국어 입력

    http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.

    변환된 중국어를 복사하여 사용하시면 됩니다.

    예시)
    • 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
    • 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
    닫기
    KCI등재후보 SCOPUS

    Inhibition of L-DOPA-Induced Increase in Dopamine Content by (1R,9S)-β-Hydrastine Hydrochloride in PC12 Cells

    한글로보기

    https://www.riss.kr/link?id=A104470186

    • 0

      상세조회
    • 0

      다운로드
    서지정보 열기
    • 내보내기
    • 내책장담기
    • 공유하기
    • 오류접수

    부가정보

    다국어 초록 (Multilingual Abstract) kakao i 다국어 번역

    The effects of BHSH on L-DOPA-induced increase in dopamine content in PC12 cells were investigated. L-DOPA treatment at 20 or 50 mM increased dopamine content after both 24 and 48 h of incubation in PC12 cells.
    However, the co-treatments of BHSH (10-50 mM) with L-DOPA (20 or 50 mM) significantly inhibited the increase of dopamine content induced by L-DOPA. BHSH treatment at 10-50 mM significantly inhibited basal aromatic L-amino acid decarboxylase (AADC) activity in a concentration-dependent manner at 15 min, and then AADC activity was rapidly recovered to the control level at about 2 h. These results indicate that the inhibition of
    AADC activity by BHSH was, in part, contributed to the early-stage decrease of dopamine content induced by LDOPA
    in PC12 cells. Taken together, it is proposed that the short-term inhibition of dopamine biosynthesis by BHSH was mediated by the regulation of tyrosine hydroxylace (TH).
    번역하기

    The effects of BHSH on L-DOPA-induced increase in dopamine content in PC12 cells were investigated. L-DOPA treatment at 20 or 50 mM increased dopamine content after both 24 and 48 h of incubation in PC12 cells. However, the co-treatments of BHSH (10-5...

    The effects of BHSH on L-DOPA-induced increase in dopamine content in PC12 cells were investigated. L-DOPA treatment at 20 or 50 mM increased dopamine content after both 24 and 48 h of incubation in PC12 cells.
    However, the co-treatments of BHSH (10-50 mM) with L-DOPA (20 or 50 mM) significantly inhibited the increase of dopamine content induced by L-DOPA. BHSH treatment at 10-50 mM significantly inhibited basal aromatic L-amino acid decarboxylase (AADC) activity in a concentration-dependent manner at 15 min, and then AADC activity was rapidly recovered to the control level at about 2 h. These results indicate that the inhibition of
    AADC activity by BHSH was, in part, contributed to the early-stage decrease of dopamine content induced by LDOPA
    in PC12 cells. Taken together, it is proposed that the short-term inhibition of dopamine biosynthesis by BHSH was mediated by the regulation of tyrosine hydroxylace (TH).

    더보기

    참고문헌 (Reference)

    1 "activity of L-DOPA decarboxylase in descrete brain regions" 1212-1213, 1970

    2 "The site ofdopamine formation in rat striatum after L-dopa administration" 1981189-197

    3 "The decarboxylationof DOPA in the parkinsonian brain in vivo studies of ananimal model" 95-101, 1980

    4 "Striatal L-dopadecarboxylase activity in Parkinsons desease in vivo implicationsfor the regulation of dopamine synthesis" -1541, 1993

    5 "Rationale for continuous dipaminomimetictherapy of Parkinsons desease" 7-10, 1989

    6 "Palliativeand prophylactic benefits of continuously administereddopaminomimetics in Parkinsons disease" 1994

    7 "Nonaminergicstriatal neurons convert exogenous L-DOPA to dopamine inParkinsonism" 558-563, 1979

    8 "Motor planning isimpaired in Parkinsons desease" 271-276, 1988

    9 "Motor fluctuations in levodopa treatment: Clinical pharmacolog" 36 : 38-42, 1996

    10 "Motor fluctuations in Parkinsonsdisease" 366-1 371, 1988

    1 "activity of L-DOPA decarboxylase in descrete brain regions" 1212-1213, 1970

    2 "The site ofdopamine formation in rat striatum after L-dopa administration" 1981189-197

    3 "The decarboxylationof DOPA in the parkinsonian brain in vivo studies of ananimal model" 95-101, 1980

    4 "Striatal L-dopadecarboxylase activity in Parkinsons desease in vivo implicationsfor the regulation of dopamine synthesis" -1541, 1993

    5 "Rationale for continuous dipaminomimetictherapy of Parkinsons desease" 7-10, 1989

    6 "Palliativeand prophylactic benefits of continuously administereddopaminomimetics in Parkinsons disease" 1994

    7 "Nonaminergicstriatal neurons convert exogenous L-DOPA to dopamine inParkinsonism" 558-563, 1979

    8 "Motor planning isimpaired in Parkinsons desease" 271-276, 1988

    9 "Motor fluctuations in levodopa treatment: Clinical pharmacolog" 36 : 38-42, 1996

    10 "Motor fluctuations in Parkinsonsdisease" 366-1 371, 1988

    11 "Mechaniam of action of short-and long-term L-DOPA treatment in Parkinsonism role of thesurviving nigrostriatal dopaminergic neurons" 149-157, 1984

    12 "Involvement of opioid and dopaminergic mechanisms" isoqui (isoqui): 436-443, 1989

    13 "Inhibitory effectsof bulbocapnine on dopamine biosynthesis in PC12 cells" 244 : 161-164, 1998a

    14 "Inhibitory effects of protoberberinealkaloids from the root of Coptic japonica on catecholaminebiosynthesis in PC12 cell" 62 : 31-34, 1996

    15 "Inhibitory effects of higenamine on dopamine content in PC12 cells" 65 : 452-455, 1999

    16 "Inhibitory effects of coralyne on dopamine content in PC12 cells" 26 : 745-747, 1998b

    17 "Inhibition of monoamine oxidase by isoquinoline derivatives" 50 : 869-877, 1995

    18 "Glucocorticoids increase catecholamine synthesis andstorage in PC12 pheochromocytoma cell culture" 364-370, 1983

    19 "Epinephrine synthesis in the PC12 pheochromocytoma cell line" hadjiconstanti (hadjiconstanti): 139-142, 1986

    20 "Effects ofL-DOPA treatment in Parkinsons disease" 868-876, 1984

    21 "Effects of hydrastine derivatives on dopaminebiosynthesis in PC12 cells" 67 : 609-613, 2001

    22 "Effect of L-dopa aloneand with benserazide on the spontaneous activity of striatalneurons in normal and 6-hydroxydopamine-lesioned rats" 121 : 331-337, 1997

    23 "Dopaminergic transplants in patients with Parkinsonsdisease Neuroanatomical correlates of clinical recovery" 144 : 41-46, 1997

    24 "Detection and function in mammals" 1991

    25 "Decarboxylationof exogenous L-DOPA in rat striatum after lesions of thedopaminergic nigrostriatal neurons the role of striatal capillaries" 244-248, 1980

    26 "Chronic parkinsonism in humans due to a product of meperidine-analog synthesis" 979-980, 1983

    27 "Chemistry of alkaloids of Corydalis-chemical studies onalkaloids of four Corydalis species from Qinghai plateau" 798-800, 1981

    28 "Aromatic L-amino acid decarboxylase: biological characterization and functional role" 26 : 681-696, 1995

    29 "Aromatic L-amino acid decarboxylase: biological characterization and functional role" 26 : 681-696, 1995

    30 "Aromatic L-amino acid decarboxylase modulation and Parkinsons desease" 106 : 91-97, 1995

    31 "Aclinicopathologic study of 100 cases of Parkinsons disease" 140-148, 1993

    32 "A clinically relevantunilateral rat model of Parkinsonian akinesia" 332-333, 1992

    더보기

    동일학술지(권/호) 다른 논문

    동일학술지 더보기

    더보기

    분석정보

    View

    상세정보조회

    0

    Usage

    원문다운로드

    0

    대출신청

    0

    복사신청

    0

    EDDS신청

    0

    동일 주제 내 활용도 TOP

    더보기

    주제

    연도별 연구동향

    연도별 활용동향

    연관논문

    연구자 네트워크맵

    공동연구자 (7)

    유사연구자 (20) 활용도상위20명

    인용정보 인용지수 설명보기

    학술지 이력

    학술지 이력
    연월일 이력구분 이력상세 등재구분
    2023 평가 해외DB학술지평가 신청대상 (해외등재 학술지 평가)
    2020-01-01 등재 등재학술지 유지 (해외등재 학술지 평가) KCI등재
    2011-01-01 등재 등재학술지 유지 (등재유지) KCI등재
    2009-01-01 등재 등재학술지 유지 (등재유지) KCI등재
    2006-01-01 등재 등재학술지 선정 (등재후보2차) KCI등재
    2005-01-01 등재 등재후보 1차 PASS (등재후보1차) KCI등재후보
    2003-07-01 등재 등재후보학술지 선정 (신규평가) KCI등재후보
    더보기

    학술지 인용정보

    학술지 인용정보
    기준연도 WOS-KCI 통합IF(2년) KCIF(2년) KCIF(3년)
    2016 0.18 0.18 0.16
    KCIF(4년) KCIF(5년) 중심성지수(3년) 즉시성지수
    0.15 0.15 0.359 0.02
    더보기

    이 자료와 함께 이용한 RISS 자료

    나만을 위한 추천자료

    해외이동버튼